[The road to elimination: an overview of neglected infectious diseases in Latin America and the Caribbean]. / El camino a la eliminación: un panorama de las enfermedades infecciosas desatendidas en América Latina y el Caribe.

Neglected infectious diseases (NID) affect mainly isolated populations living in isolation and in poor socioeconomic conditions. These diseases, by their chronic and silent nature, often affect communities with a weak political voice. This translates into very little attention or political priority; which is reflected in minimal and insufficient preventive measures, monitoring and control. However, there is evidence this situation is changing favorably in some countries of the Americas. In recent years, several resolutions (official agreement of the member countries of the Pan American Health Organization / World Health Organization-PAHO / WHO), regional and global agreements on public health; with a greater commitment from the pharmaceutical industry, and other donors and international partners in combination with the development and use of integrated action plans have allowed countries to intensify public interventions to control these diseases and thus achieve target elimination of NID. Onchocerciasis, lymphatic filariasis, Chagas disease, leprosy and trachoma blindness, among others, have been eliminated in several countries and endemic areas, regardless of the level of development of the country or geographical area where they are located. The political decision reflected in adequate financial resources in the next decade will be crucial to achieving the goals of elimination of NID (regional and national).

El camino a la eliminación: un panorama de las enfermedades infecciosas desatendidas en América Latina y el Caribe / The road to elimination: an overview of neglected infectious diseases in Latin America and the Caribbean

Las enfermedades infecciosas desatendidas (EID) afectan, principalmente, a las poblaciones que viven en condiciones aisladas y socioeconómicas de pobreza. Estas enfermedades, por su naturaleza crónica y silenciosa, aquejan con frecuencia a comunidades con voz política débil. Lo anterior se traduce en muy poca atención o prioridad política; lo que se refleja en mínimas e insuficientes acciones de prevención, vigilancia y control. Sin embargo, hay evidencia de que la situación está cambiando favorablemente en algunos países de las Américas. En los últimos años, varias resoluciones (acuerdos oficiales de los países miembros de la Organización Panamericana de la Salud/Organización Mundial de la Salud- OPS/OMS), convenios regionales y mundiales en materia de salud pública, junto a un mayor compromiso por parte de la industria farmacéutica, y otros donantes y socios internacionales, en combinación con el desarrollo y uso de los planes de acción integrados, han permitido que los países intensifiquen las intervenciones públicas hacia el control de estas enfermedades y así alcanzar los objetivos de eliminación de las EID. La oncocercosis, la filariasis linfática, la enfermedad de Chagas, la lepra y la ceguera por tracoma, entre otras, han sido eliminadas en varios países o zonas endémicas, sin importar el nivel de desarrollo del país o área geográfica donde se localizan. La voluntad política reflejada en los recursos financieros suficientes en la próxima década, serán determinantes para lograr los objetivos regionales y nacionales de eliminación de las EID...

Neglected infectious diseases (NID) affect mainly isolated populations living in isolation and in poor socioeconomic conditions. These diseases, by their chronic and silent nature, often affect communities with a weak political voice. This translates into very little attention or political priority; which is reflected in minimal and insufficient preventive measures, monitoring and control. However, there is evidence this situation is changing favorably in some countries of the Americas. In recent years, several resolutions (official agreement of the member countries of the Pan American Health Organization / World Health Organization-PAHO / WHO), regional and global agreements on public health; with a greater commitment from the pharmaceutical industry, and other donors and international partners in combination with the development and use of integrated action plans have allowed countries to intensify public interventions to control these diseases and thus achieve target elimination of NID. Onchocerciasis, lymphatic filariasis, Chagas disease, leprosy and trachoma blindness, among others, have been eliminated in several countries and endemic areas, regardless of the level of development of the country or geographical area where they are located. The political decision reflected in adequate financial resources in the next decade will be crucial to achieving the goals of elimination of NID (regional and national)...

Update on the mapping of prevalence and intensity of infection for soil-transmitted helminth infections in Latin America and the Caribbean: a call for action.

It is estimated that in Latin America and the Caribbean (LAC) at least 13.9 million preschool age and 35.4 million school age children are at risk of infections by soil-transmitted helminths (STH): Ascaris lumbricoides, Trichuris trichiura and hookworms (Necator americanus and Ancylostoma duodenale). Although infections caused by this group of parasites are associated with chronic deleterious effects on nutrition and growth, iron and vitamin A status and cognitive development in children, few countries in the LAC Region have implemented nationwide surveys on prevalence and intensity of infection. The aim of this study was to identify gaps on the mapping of prevalence and intensity of STH infections based on data published between 2000 and 2010 in LAC, and to call for including mapping as part of action plans against these infections. A total of 335 published data points for STH prevalence were found for 18 countries (11.9% data points for preschool age children, 56.7% for school age children and 31.3% for children from 1 to 14 years of age). We found that 62.7% of data points showed prevalence levels above 20%. Data on the intensity of infection were found for seven countries. The analysis also highlights that there is still an important lack of data on prevalence and intensity of infection to determine the burden of disease based on epidemiological surveys, particularly among preschool age children. This situation is a challenge for LAC given that adequate planning of interventions such as deworming requires information on prevalence to determine the frequency of needed anthelmintic drug administration and to conduct monitoring and evaluation of progress in drug coverage.

Elimination of neglected diseases in Latin America and the Caribbean: a mapping of selected diseases

Article published in the journal PLoS, volume 5, issue 2, in February of 2011. This article talks about Elimination of Neglected Diseases in Latin America and the Caribbean and the locals most affected with this neglect.

Elimination of neglected diseases in latin america and the Caribbean: a mapping of selected diseases.

In Latin America and the Caribbean, around 195 million people live in poverty, a situation that increases the burden of some infectious diseases. Neglected diseases, in particular, are often restricted to poor, marginalized sections of the population. Tools exist to combat these diseases, making it imperative to work towards their elimination. In 2009, the Pan American Health Organization (PAHO) received a mandate to support the countries in the Region in eliminating neglected diseases and other poverty-related infections. The objective of this study is to analyze the presence of selected diseases using geo-processing techniques. Five diseases with information available at the first sub-national level (states) were mapped, showing the presence of the disease ("hotspots") and overlap of diseases ("major hotspots"). In the 45 countries/territories (approximately 570 states) of the Region, there is: lymphatic filariasis in four countries (29 states), onchocerciasis in six countries (25 states), schistosomiasis in four countries (39 states), trachoma in three countries (29 states), and human rabies transmitted by dogs in ten countries (20 states). Of the 108 states with one or more of the selected diseases, 36 states present the diseases in overlapping areas ("major hotspots"). Additional information about soil-transmitted helminths was included. The analysis suggests a majority of the selected diseases are not widespread and can be considered part of an unfinished agenda with elimination as a goal. Integrated plans and a comprehensive approach, ensuring access to existing diagnostic and treatment methods, and establishing a multi-sectoral agenda that addresses social determinants, including access to adequate water and sanitation, are required. Future studies can include additional diseases, socio-economic and environmental variables.